Nick Glover
Directeur/Bestuurslid bij MEI PHARMA, INC.
Vermogen: - $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Nick Glover
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 36 | |
| Extinct | Biotechnology | 27 | |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada.
13
| Extinct | Pharmaceuticals: Major | 13 |
Pattern Pharma, Inc.
 Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada
2
| Private Company | Biotechnology | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Nick Glover via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| University of British Columbia | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
| San Diego State University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| SEQUENOM, INC. | Medical Specialties | Director/Board Member Public Communications Contact Director of Finance/CFO | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member Director/Board Member | |
| LaTrobe University | College/University | Masters Business Admin Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member | |
| University of California | College/University | Corporate Officer/Principal Undergraduate Degree | |
| NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| Queen's University | College/University | Masters Business Admin Graduate Degree | |
| FATE THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Institut Gustave Roussy EURL
 Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Tufts University | College/University | Doctorate Degree Undergraduate Degree | |
Sidney Kimmel Cancer Center
 Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Part of Sanford Burnham Prebys Medical Discovery Institute, Sidney Kimmel Cancer Center provides medical research services. The company is based in San Diego, CA. Sidney Kimmel Cancer Center was acquired by Sanford Burnham Prebys Medical Discovery Institute on June 23, 2009 for $25 million. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| SQI DIAGNOSTICS INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ANAPTYSBIO, INC. | Biotechnology | Chairman Human Resources Officer | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Public Communications Contact | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
| KURA ONCOLOGY, INC. | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Canada | 8 |
| Verenigd Koninkrijk | 3 |
| Australië | 2 |
| China | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 15 |
| Finance | 6 |
| Commercial Services | 4 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 375 |
| Corporate Officer/Principal | 188 |
| Independent Dir/Board Member | 138 |
| Undergraduate Degree | 62 |
| Chief Tech/Sci/R&D Officer | 57 |
Sterkste connecties
| Insiders | |
|---|---|
| James Topper | 52 |
| Tamar Howson | 41 |
| Peter Thompson | 39 |
| Kapil Dhingra | 39 |
| John H. Abeles | 33 |
| Donald Parfet | 31 |
| Albert Cha | 30 |
| François Thomas | 25 |
| Catherine Mackey | 24 |
| Fred Driscoll | 21 |
| Gaurav Aggarwal | 21 |
| Cheryl Cohen | 20 |
| Andrew Allen | 18 |
| Nicole Onetto | 17 |
| Charles Baltic | 15 |
- Beurs
- Insiders
- Nick Glover
- Bedrijfsconnecties
